Amphiregulin

Amphiregulin is a growth factor protein that plays a key role in cell proliferation, differentiation, and survival. It is a type of epidermal growth factor receptor (EGFR) ligand that binds to EGFR on the surface of cells, initiating downstream signaling pathways. These pathways result in an array of effects, including angiogenesis, inflammation, and cell cycle control. In addition, amphiregulin has been found to increase the production of other growth factors, such as tumor necrosis factor-alpha. Amphiregulin plays critical roles in numerous biological processes, including wound healing, embryonic development, and cancer metastasis. It has been studied in a range of contexts, including diseases such as asthma, rheumatoid arthritis, inflammatory bowel disease, and some cancers. Moreover, amphiregulin has been found to be important in regulating resistance to drugs used in the treatment of cancer. Its identification has significant implications for cancer treatment, as it provides potential new targets for therapeutic drugs.

← International Journal of Glaucoma

Related Articles

1 journal(s) found

International Journal of Glaucoma

ISSN: Coming Soon
Type: Open Access Journal
Editor-in-Chief: Gianluca SCUDERI, Sapienza University of Rome, Faculty of Medicine and Psychology, Sant Andrea Hospital.
International Journal of Glaucoma is a scientific journal dedicated to glaucoma surgery. The aim is to provide a stimulating forum for discussion of clinical scientific issues involved in diagnosing, treating and preventing glaucoma. This journal offers a rapid and time bound review for authors to submit papers on glaucoma. Each issue presents orig